B-CELL PROLYMPHOCYTIC LEUKEMIA
Clinical trials for B-CELL PROLYMPHOCYTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new B-CELL PROLYMPHOCYTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for B-CELL PROLYMPHOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells take on recurrent B-Cell cancers
Disease control OngoingThis early-stage trial tests a new cellular immunotherapy for adults with certain B-cell cancers (like lymphomas and leukemias) that have come back. Researchers take a patient's own white blood cells, modify them in the lab to better recognize and attack cancer cells, and infuse …
Matched conditions: B-CELL PROLYMPHOCYTIC LEUKEMIA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 23, 2026 11:55 UTC
-
New drug combo targets Hard-to-Treat blood cancers
Disease control OngoingThis early-phase study tests a new two-drug combination (pevonedistat and ibrutinib) in adults with chronic lymphocytic leukemia or non-Hodgkin lymphoma that has returned or no longer responds to standard therapy. The main goal is to find the safest dose and understand side effec…
Matched conditions: B-CELL PROLYMPHOCYTIC LEUKEMIA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 22, 2026 12:07 UTC
-
New drug shows promise in controlling Hard-to-Treat blood cancers
Disease control OngoingThis study tests a drug called ibrutinib in people with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or B-cell prolymphocytic leukemia (B-PLL) that has come back or not responded to prior treatment. The goal is to see how well ibrutinib controls the disea…
Matched conditions: B-CELL PROLYMPHOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: Kami Maddocks, MD • Aim: Disease control
Last updated Jun 18, 2026 11:53 UTC